Financial Risk Management at Eli Lilly and Company

            
 
Case Studies | Case Study in Business, Management, Operations, Strategy, Case Study

ICMR HOME | Case Studies Collection

Case Details:

Case Code : FINA016
Case Length : 15 Pages
Period : 2003
Pub. Date : 2003
Teaching Note :Not Available
Organization : Eli Lilly and Company
Industry : Pharmaceutical
Countries : Global

To download Financial Risk Management at Eli Lilly and Company case study (Case Code: FINA016) click on the button below, and select the case from the list of available cases:

Finance | Case Study in Management, Operations, Strategies, Business Ethics, Case Studies

Price:

For delivery in electronic format: Rs. 500;
For delivery through courier (within India): Rs. 500 + Shipping & Handling Charges extra

Finance Case Studies
Short Case Studies
View Detailed Pricing Info
How To Order This Case
Business Case Studies
Case Studies by Area
Case Studies by Industry
Case Studies by Company

Custom Search


Please note:

This case study was compiled from published sources, and is intended to be used as a basis for class discussion. It is not intended to illustrate either effective or ineffective handling of a management situation. Nor is it a primary information source.



Chat with us

Strategic Management Formulation, Implementation, & Control, 12e

Please leave your feedback

Leave Your Feedback

ICMR India ICMR India ICMR India ICMR India RSS Feed

<< Previous

Introduction

Eli Lilly (Lilly), one of the leading players in the global pharmaceuticals industry was best known for its popular antidepressants, Prozac and Serafem. The company offered medicines for a wide variety of ailments. Top drugs included Gemzar (pancreatic cancer), Evista (osteoporosis), Humalog (insulin), Actos (Type 2 diabetes), and Zyprexa (schizophrenia and bipolar disorder).

In addition to neurological, oncological, and diabetes drugs, the company also made antibiotics, growth hormones, anti-ulcer agents, and cardiovascular therapies, as well as animal health products.

Finance | Case Study in Management, Operations, Strategies, Finance, Case Studies

Lilly lost its lucrative patent protection for Prozac in August 2001. The company hoped launches of osteoporosis treatment Forteo, antidepressant Duloxetine, and erectile dysfunction treatment Cialis could replace the lost income. Lilly had some 40 other drugs in development, including treatments for sepsis, cancer, and diabetes.

Financial Risk Management at Eli Lilly and Company - Next Page>>


Custom Search



Marketing Financial Products
Textbooks Collection

Case Studies in Finance Vol III

Case Studies in Finance Vol III
e-Book on Case Studies in Finance

Case Study Volumes Collection

 

Case Studies Links:- Case Studies, Short Case Studies, Simplified Case Studies.

Other Case Studies:- Multimedia Case Studies, Cases in Other Languages.

Business Reports Link:- Business Reports.

Books:- Textbooks, Work Books, Case Study Volumes.